Short Interest in Nutex Health Inc. (NASDAQ:NUTX) Expands By 76.0%

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) was the target of a large increase in short interest in May. As of May 15th, there was short interest totalling 208,900 shares, an increase of 76.0% from the April 30th total of 118,700 shares. Based on an average daily volume of 114,200 shares, the short-interest ratio is presently 1.8 days. Approximately 5.9% of the company's stock are sold short.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on NUTX. Wall Street Zen cut Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd. Benchmark increased their target price on Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research report on Thursday, May 15th. Finally, Maxim Group increased their target price on Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th.

Nutex Health Price Performance

Shares of Nutex Health stock traded up $0.22 on Monday, hitting $167.96. The company's stock had a trading volume of 93,175 shares, compared to its average volume of 70,155. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. Nutex Health has a 1 year low of $4.16 and a 1 year high of $184.28. The firm has a fifty day moving average price of $126.56 and a 200-day moving average price of $72.33. The company has a market capitalization of $934.87 million, a price-to-earnings ratio of -17.89 and a beta of -0.10.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, topping the consensus estimate of ($0.15) by $2.71. The business had revenue of $211.79 million for the quarter, compared to analysts' expectations of $81.09 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Insiders Place Their Bets

In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of the stock in a transaction dated Tuesday, April 8th. The shares were acquired at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the transaction, the chief financial officer now directly owns 4,888 shares of the company's stock, valued at approximately $399,887.28. The trade was a 25.72% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 38.52% of the company's stock.

Institutional Trading of Nutex Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bank of America Corp DE increased its holdings in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares during the last quarter. Northern Trust Corp purchased a new stake in Nutex Health in the 4th quarter worth approximately $200,000. Baader Bank Aktiengesellschaft purchased a new stake in shares of Nutex Health during the 4th quarter valued at $206,000. Millennium Management LLC acquired a new position in shares of Nutex Health during the 4th quarter valued at $213,000. Finally, World Investment Advisors acquired a new position in Nutex Health in the 4th quarter worth $217,000. Hedge funds and other institutional investors own 5.32% of the company's stock.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.